XML 77 R69.htm IDEA: XBRL DOCUMENT v3.20.1
REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Noncontrolling Interest (Details)
shares in Millions, $ in Millions
6 Months Ended
Apr. 03, 2020
€ / shares
Apr. 03, 2020
USD ($)
Apr. 03, 2020
USD ($)
shares
Apr. 30, 2019
Apr. 29, 2019
Sep. 28, 2018
Apr. 30, 2015
Noncontrolling Interest              
Balance at September 27, 2019   $ 3.3          
Net earnings attributable to noncontrolling interests   (0.1)          
Other, including foreign currency remeasurement   0.0          
Balance at April 3, 2020   3.2          
Direct Conversion AB              
Noncontrolling Interest [Line Items]              
Percentage of voting interests acquired     98.70% 98.20% 98.20%    
MeVis Medical Solutions AG (MeVis)              
Noncontrolling Interest [Line Items]              
Percentage of voting interests acquired             73.50%
Annual recurring compensation (in euros per share) | € / shares € 0.95            
Temporary equity, redemption price per share (in euros per share) | € / shares € 19.77            
Temporary equity, shares outstanding (in shares) | shares     0.5        
Redeemable Noncontrolling Interests              
Balance at September 27, 2019   10.5          
Net earnings attributable to noncontrolling interests   0.2          
Other, including foreign currency remeasurement   (0.2)          
Balance at April 3, 2020   $ 10.5 $ 10.5        
Joint Venture In Saudi Arabia              
Noncontrolling Interest [Line Items]              
Majority voting rights, percent           75.00%  
Noncontrolling interest, ownership percentage by noncontrolling owners           25.00%  
MeVis Medical Solutions AG (MeVis)              
Noncontrolling Interest [Line Items]              
Noncontrolling interest, ownership percentage by noncontrolling owners     26.50%